| Produkt-Name |
Voacamin |
| Synonyme |
; 6,9-Methano-5H-pyrido(1',2':1,2)azepino(4,5-b)indol-6-carbons?ure; B 606109; Kristalline Verbindung aus Voacanga afracina; NSC 82591; VOAKAMIN; Voacanginin; Vocamin; 12-Methoxy-13-((3alpha)-17-methoxy-17-oxovobasan-3-yl)ibogamin-18-carbons?uremethylester; Ibogamin-18-carbons?ure, 12-Methoxy-13-((3alpha)-17-methoxy-17-oxovobasan-3-yl)-, Methylester (9CI); Methyl-12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamin-18-carboxylat; Voacamin (8CI); Methyl-12-methoxy-13-[(3alpha,19Z)-17-methoxy-17-oxovobasan-3-yl]ibogamin-18-carboxylat; Methyl(2alpha)-12-methoxy-13-[(3alpha,5alpha,19E)-17-methoxy-17-oxovobasan-3-yl]ibogamin-18-carboxylat |
| Englischer Name |
Voacamine; 6,9-Methano-5H-pyrido(1',2':1,2)azepino(4,5-b)indole-6-carboxylic; B 606109; Crystalline compound from Voacanga afracina; NSC 82591; VOACAMINE; Voacanginine; Vocamine; 12-Methoxy-13-((3alpha)-17-methoxy-17-oxovobasan-3-yl)ibogamine-18-carboxylic acid methyl ester; Ibogamine-18-carboxylic acid, 12-methoxy-13-((3alpha)-17-methoxy-17-oxovobasan-3-yl)-, methyl ester (9CI); Methyl 12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate; Voacamine (8CI); methyl 12-methoxy-13-[(3alpha,19Z)-17-methoxy-17-oxovobasan-3-yl]ibogamine-18-carboxylate; methyl (2alpha)-12-methoxy-13-[(3alpha,5alpha,19E)-17-methoxy-17-oxovobasan-3-yl]ibogamine-18-carboxylate |
| Molekulare Formel |
C43H52N4O5 |
| Molecular Weight |
704.8968 |
| InChI |
InChI=1/C43H52N4O5/c1-7-24-15-23-20-43(42(49)52-6)39-27(13-14-47(21-23)40(24)43)29-19-36(50-4)30(17-34(29)45-39)31-16-28-25(8-2)22-46(3)35(37(28)41(48)51-5)18-32-26-11-9-10-12-33(26)44-38(31)32/h8-12,17,19,23-24,28,31,35,37,40,44-45H,7,13-16,18,20-22H2,1-6H3/b25-8-/t23-,24-,28-,31+,35+,37?,40-,43+/m0/s1 |
| CAS Registry Number |
3371-85-5 |
| EINECS |
222-151-3 |
| Molecular Structure |
|
| Dichte |
1.309g/cm3 |
| Brechungsindex |
1.674 |
|
DE
CN
CZ
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PL
PT
RU
SA
TR